Company profile ACXP

Acurx Pharmaceuticals Inc
Description of the company is not available.
Quarter analysis & expected interestLast update: February 08 2024 12:56:48.

After 39 days of this quarter the interest is at 21.0. Based on that we can calculate that during remaining 52 days it will total up to 49.0.
Acurx Pharmaceuticals expected interest is significantly lower compared to previous quarter (-87.5%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201968
106
55.9% QoQ
167
57.5% QoQ
76
-54.5% QoQ
2020 145
113.2% YoY 90.8% QoQ
17
-84.0% YoY -88.3% QoQ
0
-100.0% YoY -100.0% QoQ
24
-68.4% YoY inf% QoQ
2021 0
-100.0% YoY -100.0% QoQ
284
1570.6% YoY inf% QoQ
247
inf% YoY -13.0% QoQ
92
283.3% YoY -62.8% QoQ
2022 80
inf% YoY -13.0% QoQ
116
-59.2% YoY 45.0% QoQ
132
-46.6% YoY 13.8% QoQ
68
-26.1% YoY -48.5% QoQ
2023 69
-13.8% YoY 1.5% QoQ
133
14.7% YoY 92.8% QoQ
91
-31.1% YoY -31.6% QoQ
393
477.9% YoY 331.9% QoQ
2024 21
-69.6% YoY -94.7% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Acurx Pharmaceuticals search interestLast update: February 08 2024 12:56:47.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:56:50.

The average 5 years interest of Acurx Pharmaceuticals was 8.92 per week.
The last year interest of Acurx Pharmaceuticals compared to the last 5 years has changed by 37.56%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 36.94%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Ibezapolstat to provide analysis

Correlation between past revenue and Ibezapolstat search interest

There is not enough data for Ibezapolstat to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Ibezapolstat to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for ACX-375C to provide analysis

Correlation between past revenue and ACX-375C search interest

There is not enough data for ACX-375C to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for ACX-375C to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 12:56:56.

After 39 days of this quarter the interest is at 12.0. Based on that we can calculate that during remaining 52 days it will total up to 28.0.
Clostridium difficile treatment expected interest is significantly lower compared to previous quarter (-92.5%) and same quarter last year (-90.0%).

YearQ1Q2Q3Q4
2019105
345
228.6% QoQ
254
-26.4% QoQ
327
28.7% QoQ
2020 253
141.0% YoY -22.6% QoQ
177
-48.7% YoY -30.0% QoQ
167
-34.3% YoY -5.6% QoQ
165
-49.5% YoY -1.2% QoQ
2021 284
12.3% YoY 72.1% QoQ
272
53.7% YoY -4.2% QoQ
138
-17.4% YoY -49.3% QoQ
347
110.3% YoY 151.4% QoQ
2022 282
-0.7% YoY -18.7% QoQ
255
-6.2% YoY -9.6% QoQ
260
88.4% YoY 2.0% QoQ
208
-40.1% YoY -20.0% QoQ
2023 279
-1.1% YoY 34.1% QoQ
289
13.3% YoY 3.6% QoQ
133
-48.8% YoY -54.0% QoQ
374
79.8% YoY 181.2% QoQ
2024 12
-95.7% YoY -96.8% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Clostridium difficile treatment search interestLast update: February 08 2024 12:56:56.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:56:57.

The average 5 years interest of Clostridium difficile treatment was 18.87 per week.
The last year interest of Clostridium difficile treatment compared to the last 5 years has changed by 4.56%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -9.83%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 12:57:01.

After 39 days of this quarter the interest is at 204.0. Based on that we can calculate that during remaining 52 days it will total up to 476.0.
That appears to be equal to previous quarter and same quarter last year.

YearQ1Q2Q3Q4
2019111
212
91.0% QoQ
213
0.5% QoQ
275
29.1% QoQ
2020 230
107.2% YoY -16.4% QoQ
223
5.2% YoY -3.0% QoQ
247
16.0% YoY 10.8% QoQ
254
-7.6% YoY 2.8% QoQ
2021 256
11.3% YoY 0.8% QoQ
232
4.0% YoY -9.4% QoQ
194
-21.5% YoY -16.4% QoQ
303
19.3% YoY 56.2% QoQ
2022 314
22.7% YoY 3.6% QoQ
458
97.4% YoY 45.9% QoQ
259
33.5% YoY -43.4% QoQ
356
17.5% YoY 37.5% QoQ
2023 424
35.0% YoY 19.1% QoQ
316
-31.0% YoY -25.5% QoQ
311
20.1% YoY -1.6% QoQ
465
30.6% YoY 49.5% QoQ
2024 204
-51.9% YoY -56.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Antibiotics for bacterial infections search interestLast update: February 08 2024 12:57:01.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:57:03.

The average 5 years interest of Antibiotics for bacterial infections was 22.44 per week.
The last year interest of Antibiotics for bacterial infections compared to the last 5 years has changed by 28.57%.
The interest for Antibiotics for bacterial infections is trending.
The last year interest is quite higher compared to 5 years ago. It has increased by 70.91%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acurx Pharmaceuticals jobs to provide analysis

Correlation between past revenue and Acurx Pharmaceuticals jobs search interest

There is not enough data for Acurx Pharmaceuticals jobs to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acurx Pharmaceuticals jobs to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acurx Pharmaceuticals reviews to provide analysis

Correlation between past revenue and Acurx Pharmaceuticals reviews search interest

There is not enough data for Acurx Pharmaceuticals reviews to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acurx Pharmaceuticals reviews to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Acurx Pharmaceuticals New York to provide analysis

Correlation between past revenue and Acurx Pharmaceuticals New York search interest

There is not enough data for Acurx Pharmaceuticals New York to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Acurx Pharmaceuticals New York to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 08 2024 12:57:11.

After 39 days of this quarter the interest is at 45.0. Based on that we can calculate that during remaining 52 days it will total up to 105.0.
Acurx Pharmaceuticals -stock -company expected interest is significantly lower compared to previous quarter (-44.1%) but similar to same quarter last year.

YearQ1Q2Q3Q4
201926
34
30.8% QoQ
88
158.8% QoQ
148
68.2% QoQ
2020 98
276.9% YoY -33.8% QoQ
129
279.4% YoY 31.6% QoQ
78
-11.4% YoY -39.5% QoQ
249
68.2% YoY 219.2% QoQ
2021 43
-56.1% YoY -82.7% QoQ
153
18.6% YoY 255.8% QoQ
114
46.2% YoY -25.5% QoQ
34
-86.3% YoY -70.2% QoQ
2022 82
90.7% YoY 141.2% QoQ
82
-46.4% YoY 0.0% QoQ
135
18.4% YoY 64.6% QoQ
113
232.4% YoY -16.3% QoQ
2023 113
37.8% YoY 0.0% QoQ
106
29.3% YoY -6.2% QoQ
168
24.4% YoY 58.5% QoQ
188
66.4% YoY 11.9% QoQ
2024 45
-60.2% YoY -76.1% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Acurx Pharmaceuticals -stock -company search interestLast update: February 08 2024 12:57:11.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 08 2024 12:57:12.

The average 5 years interest of Acurx Pharmaceuticals -stock -company was 8.53 per week.
The last year interest of Acurx Pharmaceuticals -stock -company compared to the last 5 years has changed by 18.76%.
This is something to be checked.
The last year interest is quite higher compared to 5 years ago. It has increased by 78.03%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for ACXP
Earnings date: 2024-03-14 After close
Company name: Acurx Pharmaceuticals Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-05-12T07:01:00-04:00

PR Newswire
Acurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update

2026-05-04T08:00:00-04:00

PR Newswire
Acurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026

2026-04-29T08:00:00-04:00

PR Newswire
Acurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase

2026-04-20T08:00:00-04:00

PR Newswire
Acurx Pharmaceuticals to Discuss First Quarter 2026 Financial Results on May 12, 2026 Conference Call and Provide Business Update

2026-04-16T16:01:00-04:00

PR Newswire
Acurx Pharmaceuticals, Inc. Announces Closing of up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

2026-04-16T08:00:00-04:00

PR Newswire
Acurx Pharmaceuticals, Inc. Announces up to $7.1 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

2026-03-30T07:01:00-04:00

PR Newswire
Korean Patent Office Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors

2026-03-13T07:01:00-04:00

PR Newswire
Acurx Pharmaceuticals, Inc. Reports Full Year and Fourth Quarter Results and Provides Business Update

2026-03-09T08:01:00-04:00

PR Newswire
Acurx Announces New Ibezapolstat Clinical Trial Program in Patients with Recurrent CDI That Has the Potential to Shift the Paradigm of Treatment and Prevention of C. difficile Infection

2026-02-16T08:01:00-05:00

PR Newswire
Acurx Pharmaceuticals to Discuss Full Year and Fourth Quarter 2025 Financial Results on March 13, 2026 Conference Call and Provide Business Update

2026-02-02T08:00:00-05:00

PR Newswire
USPTO Grants Acurx Pharmaceuticals New Patent for DNA Polymerase IIIC Inhibitors

2025-11-12T07:01:00-05:00

PR Newswire
Acurx Pharmaceuticals, Inc. Reports Third Quarter Results and Provides Business Update

2025-11-10T08:00:00-05:00

PR Newswire
Acurx Announces Publication in the Nature Communications Scientific Journal Documenting its Unique Targeting of DNA pol IIIC Gram-positive Priority Pathogens

2025-10-28T08:00:00-04:00

PR Newswire
Acurx Announces New Data on its DNA pol IIIC Inhibitor Antibiotics Demonstrating a Potential Class Effect of Gut Microbiome Selectivity Presented at IDWeek 2025 Scientific Conference

2025-10-27T08:00:00-04:00

PR Newswire
Acurx Pharmaceuticals to Discuss Third Quarter 2025 Financial Results on November 12, 2025 Conference Call and Provide Business Update